Prostate cancer is cancer that occurs in the prostate. Prostate cancer is the most frequently diagnosed male cancer and the fifth leading cancer-related mortality rate in men around the world. In 2020, there were 1,414,249 newly diagnosed cases and 375,000 fatalities worldwide due to this illness. The majority of prostate tumors grow slowly, are low-grade, have a modest risk, and are not particularly aggressive.
Age - Men under the age of 40 are less likely to develop prostate cancer than older men, although the risk increases significantly after age 50. Men older than 65 are infected by prostate cancer in about 6 out of 10 cases
Race/ethnicity - A man's risk of having prostate cancer is more than doubled if his father or sibling has the condition
Gene changes - Inherited mutations in the BRCA1 or BRCA2 genes linked to an elevated risk of breast and ovarian cancer can also raise the risk of prostate cancer in men (especially mutations in BRCA2)
Prostate cancer risk is higher in men who have Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), a disorder caused by inherited gene alterations
Screening for prostate cancer - Prostate screening tests include:
1. Prostatectomy – includes the removal of affected tissues and lymph nodes of the prostate gland. This can be done by 2 techniques:
2. Radiation therapy includes -
3. Freezing or heating prostate tissue -
4. Chemotherapy
5. Immunotherapy
6. Targeted drug therapy
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
The New Canadian Guidelines for Drinking at High Risk, AUD.
2.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
3.
Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?
4.
Three out of ten breast cancers detected between screenings, study finds
5.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
1.
Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies
2.
The Importance of Maintaining Normal Calcium Levels in Your Body
3.
Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights
4.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
5.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Navigating the Complexities of Ph Negative ALL - Part IV
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation